Bill
Bill > HR2920
US HR2920
US HR2920CARERS Act of 2017 Compassionate Access, Research Expansion, and Respect States Act of 2017
summary
Introduced
06/15/2017
06/15/2017
In Committee
06/16/2017
06/16/2017
Crossed Over
Passed
Dead
12/31/2018
12/31/2018
Introduced Session
115th Congress
Bill Summary
CARERS Act of 2017 Compassionate Access, Research Expansion, and Respect States Act of 2017 This bill amends the Controlled Substances Act to provide that the Act's regulatory controls and administrative, civil, and criminal penalties do not apply to a person who produces, possesses, distributes, dispenses, administers, tests, recommends, or delivers medical marijuana in compliance with state law. The bill also: excludes "cannabidiol" (CBD) from the definition of "marijuana"; limits the concentration of delta-9-tetrahydrocannabinol (THC) in CBD to 0.3 percent on a dry weight basis; and deems marijuana grown or processed to make CBD, in accordance with state law, to comply with the THC concentration limit unless the Drug Enforcement Administration (DEA) determines state law to be unreasonable. The bill directs the Department of Health and Human Services (HHS) to terminate the Public Health Service's interdisciplinary review process that is used to evaluate applications for medical marijuana research. The DEA must license manufacturers and distributors of marijuana for medical research; HHS must register practitioners to conduct research; and the Department of Veterans Affairs (VA) must authorize VA health care providers to provide recommendations and opinions to veterans regarding participation in their states' marijuana programs.
AI Summary
This bill, the Compassionate Access, Research Expansion, and Respect States (CARERS) Act of 2017, aims to extend the principle of federalism to state drug policy, provide access to medical marijuana, and enable research into the medicinal properties of marijuana. The key provisions include: 1) exempting persons acting in compliance with state medical marijuana laws from the federal Controlled Substances Act; 2) excluding "cannabidiol" (CBD) from the definition of "marijuana" and setting a limit on the concentration of delta-9-tetrahydrocannabinol (THC) in CBD; 3) directing the Department of Health and Human Services to terminate the review process for medical marijuana research applications and requiring the Drug Enforcement Administration to issue licenses for marijuana research; and 4) authorizing Department of Veterans Affairs healthcare providers to provide recommendations and opinions to veterans regarding their participation in state marijuana programs.
Committee Categories
Business and Industry, Health and Social Services
Sponsors (31)
Steve Cohen (D)*,
Justin Amash (LIB),
Earl Blumenauer (D),
Brendan Boyle (D),
Lou Correa (D),
Carlos Curbelo (R),
Peter DeFazio (D),
Drew Ferguson (R),
Matt Gaetz (R),
Tom Garrett (R),
Raúl Grijalva (D),
Duncan Hunter (R),
Hank Johnson (D),
Walter Jones (R),
Ted Lieu (D),
David Loebsack (D),
Zoe Lofgren (D),
Alan Lowenthal (D),
Michelle Lujan Grisham (D),
Thomas Massie (R),
Tom McClintock (R),
Eleanor Holmes Norton (D),
Beto O'Rourke (D),
Jared Polis (D),
Mike Quigley (D),
Tom Rice (R),
Dana Rohrabacher (R),
Mark Sanford (R),
Carol Shea-Porter (D),
David Young (R),
Don Young (R),
Last Action
Referred to the Subcommittee on Health. (on 06/16/2017)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/115th-congress/house-bill/2920/all-info |
| BillText | https://www.congress.gov/115/bills/hr2920/BILLS-115hr2920ih.pdf |
| Bill | https://www.congress.gov/115/bills/hr2920/BILLS-115hr2920ih.pdf.pdf |
Loading...